These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6667755)

  • 1. [Parathyroid function and uric acid metabolism].
    Yoneda M; Takatsuki K; Tomita A
    Nihon Naibunpi Gakkai Zasshi; 1983 Nov; 59(11):1738-51. PubMed ID: 6667755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment.
    Kruse K; Kracht U; Wohlfart K; Kruse U
    Eur J Pediatr; 1989 Apr; 148(6):535-9. PubMed ID: 2744015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The modulatory effect of endogenous parathyroid hormone on the action of hydrochlorothiazide in pseudohypoparathyroidism type I.
    Mizunashi K; Furukawa Y; Abe K; Yoshinaga K
    Calcif Tissue Int; 1994 Jun; 54(6):473-6. PubMed ID: 8082049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudohypoparathyroidism and idiopathic hypoparathyroidism: relationship between serum calcium and parathyroid hormone levels and urinary cyclic adenosine-3',5'-monophosphate response to parathyroid extract.
    Werder EA; Fischer JA; Illig R; Kind HP; Bernasconi S; Fanconi A; Prader A
    J Clin Endocrinol Metab; 1978 Jun; 46(6):872-9. PubMed ID: 233700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of pseudohypoparathyroidism type I from the aspect of urinary excretion of calcium and serum levels of parathyroid hormone.
    Mizunashi K; Furukawa Y; Sohn HE; Miura R; Yumita S; Yoshinaga K
    Calcif Tissue Int; 1990 Apr; 46(4):227-32. PubMed ID: 2108792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between serum intact parathyroid hormone and calcium in idiopathic hypoparathyroidism.
    Mizunashi K; Furukawa Y; Abe K; Yoshinaga K
    Calcif Tissue Int; 1993 Dec; 53(6):378-83. PubMed ID: 8293350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sigmoidal curve shift in idiopathic hypoparathyroidism and pseudohypoparathyroidism.
    Mizunashi K; Furukawa Y; Goto MM; Abe K
    Calcif Tissue Int; 1998 Apr; 62(4):290-4. PubMed ID: 9504951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)].
    Stögmann W
    Wien Klin Wochenschr Suppl; 1975; 33():1-15. PubMed ID: 176830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
    Lambert PW; Hollis BW; Bell NH; Epstein S
    J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urinary phosphate and cyclic adenosine monophosphate response to intravenous administration of synthetic human parathyroid hormone-(1-34) in idiopathic hypoparathyroidism, pseudohypoparathyroidism, pseudopseudohypoparathyroidism and normal subjects].
    Fukami T; Fujita T; Yoshimoto Y; Fukase M; Imai Y; Sakaguchi K; Ogata E; Furukawa Y; Suzuki H; Takebe K
    Nihon Naibunpi Gakkai Zasshi; 1984 Mar; 60(3):159-70. PubMed ID: 6090236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and urinary uric acid in primary hyperparathyroidism.
    Yamamoto S; Hiraishi K; Nakamura S; Ghazizadeh M
    Br J Urol; 1987 May; 59(5):386-9. PubMed ID: 3594096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal responsiveness to parathyroid hormone in pseudohypoparathyroidism.
    Kanatani M; Sugimoto T; Kaji H; Ikeda K; Chihara K
    Eur J Endocrinol; 2001 Mar; 144(3):263-9. PubMed ID: 11248746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of plasma 1,25-dihydroxyvitamin D in the human PTH(1-34) infusion test: an improved index for the diagnosis of idiopathic hypoparathyroidism and pseudohypoparathyroidism.
    Miura R; Yumita S; Yoshinaga K; Furukawa Y
    Calcif Tissue Int; 1990 May; 46(5):309-13. PubMed ID: 2159833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resetting of parathyroid hormone secretion after vitamin D3 treatment in hypoparathyroidism and after parathyroid adenectomy in primary hyperparathyroidism.
    Mizunashi K; Furukawa Y; Abe K; Takaya K; Yoshinaga K
    Calcif Tissue Int; 1995 Jul; 57(1):30-4. PubMed ID: 7671162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of endogenous parathyroid hormone, exogenous calcitonin, and dibutyryl cyclic AMP on urinary excretion of N-acetyl-beta-D-glucosaminidase.
    Mizunashi K; Furukawa Y; Yoshinaga K
    Calcif Tissue Int; 1994 Mar; 54(3):186-94. PubMed ID: 8055364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of idiopathic hypoparathyroidism and dietary vitamin D deficiency: the requirement for calcium and vitamin D for bone, but not renal responsiveness to PTH.
    Gerblich AA; Genuth SM; Haddad JG
    J Clin Endocrinol Metab; 1977 Mar; 44(3):507-13. PubMed ID: 838850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased serum concentrations of 1,25(OH)2-vitamin D3 in patients with gout.
    Takahashi S; Yamamoto T; Moriwaki Y; Tsutsumi Z; Yamakita J; Higashino K
    Metabolism; 1998 Mar; 47(3):336-8. PubMed ID: 9500573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for bone remodeling but lack of calcium mobilization response to parathyroid hormone in pseudohypoparathyroidism.
    Breslau NA; Moses AM; Pak CY
    J Clin Endocrinol Metab; 1983 Sep; 57(3):638-44. PubMed ID: 6688258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical studies using a highly sensitive radioimmunoassay for mid-region and carboxy terminus of parathyroid hormone in normal, hypo- and hypercalcemic states].
    Fukase M; Fujita T; Matsumoto T; Ogata E; Iijima T; Takezawa J; Saito K; Ishige H; Fujimoto M
    Nihon Naibunpi Gakkai Zasshi; 1989 Aug; 65(8):807-27. PubMed ID: 2553507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.